ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

November Opens With Bears in Charge

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short Sellers and Earnings Collide

Short sellers enter November with heavy positions across semiconductors and beaten-down consumer names. Hertz carries an ORTEX short score of 86, with 73.5% of its free float shorted and cost to borrow at 150% APR. Available shares to borrow have run to zero. Wolfspeed sits at 88.6% short interest of free float, also with no borrow left. The stock is down 63% year-to-date and its 14-day RSI stands at just 39.6.

Against that bearish backdrop, Wall Street is lifting targets on defensives. Regeneron saw its consensus price target jump to $924 from $869, a 6% revision. L3Harris Technologies and General Dynamics both received quiet target bumps ahead of a week that is heavy with earnings.

Auto Sector in Focus

The biggest earnings story of the week is autos. Ferrari reports Tuesday. Austrian car registrations, a leading indicator for its revenue tracked by ORTEX, are running 75% below the same quarter last year. Honda Motor reports Thursday, with Japanese car registrations pointing 10% lower year-on-year. Renault faces a split picture: Dutch registrations are down 19%, while Austrian data points 6% higher. Polestar confronts similarly mixed signals, with Dutch leads down 37% but German data up 32%.

Index Radar: Xero on the Knife-Edge

The MSCI World November review, announcing on 11 November, has Xero sitting just 2.3% above its exit line at a $7.5B market cap. ORTEX Index Rebalance Radar puts the deletion probability at 52%. Forced selling would reach $522M, or 12.5 days of normal volume. Meanwhile, UMB Financial saw its Russell 2000 deletion odds jump overnight from 55% to 90%, with $1.3B of potential forced selling at stake.

European Deal Watch

CVC Capital Partners' tender offer for Italian pharma firm Recordati carries an 82% completion probability. The window opens 2 November. If it closes, Recordati leaves the FTSE MIB, with $218M of forced selling expected at 11.2 days of volume.

Stocks in this article

How this article was generated

Generated
1 Nov 2026, 16:50
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowORTEX Alpha signalsORTEX Alpha signalsAnalyst consensusAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.